Santosh Timilsina

853 total citations
22 papers, 566 citations indexed

About

Santosh Timilsina is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Santosh Timilsina has authored 22 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Santosh Timilsina's work include RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers) and Cancer Mechanisms and Therapy (3 papers). Santosh Timilsina is often cited by papers focused on RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers) and Cancer Mechanisms and Therapy (3 papers). Santosh Timilsina collaborates with scholars based in United States, Slovakia and Nepal. Santosh Timilsina's co-authors include Yidong Chen, Manjeet K. Rao, Panneerdoss Subbarayalu, Subapriya Rajamanickam, Nourhan Abdelfattah, Benjamin Onyeagucha, Pooja Yadav, Tabrez A. Mohammad, Suryavathi Viswanadhapalli and Yufei Huang and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Santosh Timilsina

21 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Santosh Timilsina United States	9	490	243	67	52	38	22	566
Benjamin Onyeagucha United States	9	474 1.0×	279 1.1×	63 0.9×	43 0.8×	35 0.9×	13	575
Sarbajeet Nagdas United States	8	288 0.6×	123 0.5×	146 2.2×	30 0.6×	34 0.9×	15	502
Yao Xu China	13	462 0.9×	334 1.4×	44 0.7×	9 0.2×	23 0.6×	27	571
Hengyu Li China	11	470 1.0×	394 1.6×	96 1.4×	8 0.2×	30 0.8×	17	631
Danny Misiak Germany	16	495 1.0×	323 1.3×	57 0.9×	15 0.3×	19 0.5×	25	614
Matthew Tegowski United States	6	282 0.6×	133 0.5×	59 0.9×	28 0.5×	9 0.2×	12	346
Shufang Mei China	12	436 0.9×	170 0.7×	59 0.9×	76 1.5×	9 0.2×	20	604
Yuxiang Qiu China	11	344 0.7×	247 1.0×	82 1.2×	10 0.2×	14 0.4×	17	482
Xiaoge Hu China	13	445 0.9×	340 1.4×	123 1.8×	29 0.6×	35 0.9×	26	596

Countries citing papers authored by Santosh Timilsina

Since Specialization

Citations

This map shows the geographic impact of Santosh Timilsina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santosh Timilsina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santosh Timilsina more than expected).

Fields of papers citing papers by Santosh Timilsina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santosh Timilsina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santosh Timilsina. The network helps show where Santosh Timilsina may publish in the future.

Co-authorship network of co-authors of Santosh Timilsina

This figure shows the co-authorship network connecting the top 25 collaborators of Santosh Timilsina. A scholar is included among the top collaborators of Santosh Timilsina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santosh Timilsina. Santosh Timilsina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Subbarayalu, Panneerdoss, Pooja Yadav, Santosh Timilsina, et al.. (2023). The RNA Demethylase ALKBH5 Maintains Endoplasmic Reticulum Homeostasis by Regulating UPR, Autophagy, and Mitochondrial Function. Cells. 12(9). 1283–1283. 3 indexed citations

Venkata, Prabhakar Pitta, Santosh Timilsina, Deepika Singh, et al.. (2023). Abstract P3-07-19: Anti-depressant Amitriptyline Augments the Efficacy of Tamoxifen in ER positive breast cancer. Cancer Research. 83(5_Supplement). P3–7. 1 indexed citations

Venkata, Prabhakar Pitta, Santosh Timilsina, Panneerdoss Subbarayalu, et al.. (2023). Abstract 1665: Imipramine enhances the efficacy of lomustine by regulating WNT-β-catenin signaling in glioblastoma. Cancer Research. 83(7_Supplement). 1665–1665. 1 indexed citations

Yadav, Pooja, Panneerdoss Subbarayalu, Saif Nirzhor, et al.. (2022). M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression. Cancer Research. 82(10). 1872–1889. 59 indexed citations

Timilsina, Santosh, Subapriya Rajamanickam, Panneerdoss Subbarayalu, et al.. (2022). The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events. Cancer Letters. 540. 215717–215717. 20 indexed citations

Subbarayalu, Panneerdoss, Subapriya Rajamanickam, Suryavathi Viswanadhapalli, et al.. (2021). Abstract PS19-14: Matrin3 inhibits breast cancer growth by suppressing microtubule nucleation protein MZT2B. Cancer Research. 81(4_Supplement). PS19–14. 1 indexed citations

Timilsina, Santosh, Ismail Jatoi, Yidong Chen, et al.. (2020). Abstract 2975: Imipramine, an FDA approved anti-depressant, suppresses triple negative breast cancer growth and progression through inhibition of FOXM1 and DNA repair pathways. Cancer Research. 80(16_Supplement). 2975–2975. 2 indexed citations

Timilsina, Santosh, Subapriya Rajamanickam, Ismail Jatoi, et al.. (2020). Abstract P3-05-05: Imipramine, an FDA approved anti-depressant, suppresses triple negative breast cancer growth and progression through inhibition of FOXM1 and DNA repair pathways. Cancer Research. 80(4_Supplement). P3–5. 1 indexed citations

Rajamanickam, Subapriya, et al.. (2020). Abstract P3-03-10: Targeting Wnt/β-catenin pathway by antidepressant imipramine for triple negative breast cancer treatment. Cancer Research. 80(4_Supplement). P3–3. 1 indexed citations

10.

Wei, Zhen, Panneerdoss Subbarayalu, Santosh Timilsina, et al.. (2018). Topological Characterization of Human and Mouse m⁵C Epitranscriptome Revealed by Bisulfite Sequencing. International Journal of Genomics. 2018. 1–19. 20 indexed citations

11.

Abdelfattah, Nourhan, Subapriya Rajamanickam, Panneerdoss Subbarayalu, et al.. (2018). MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma. Nature Communications. 9(1). 4541–4541. 45 indexed citations

12.

Subbarayalu, Panneerdoss, Vijay Kumar Eedunuri, Pooja Yadav, et al.. (2018). Cross-talk among writers, readers, and erasers of m ⁶ A regulates cancer growth and progression. Science Advances. 4(10). eaar8263–eaar8263. 271 indexed citations

13.

Abdelfattah, Nourhan, Subapriya Rajamanickam, Santosh Timilsina, et al.. (2018). Abstract A45: Tumor suppressor miR-584-5p regulates MYC and sensitizes MYC-amplified medulloblastoma to vincristine and ionizing radiation. Cancer Research. 78(19_Supplement). A45–A45. 1 indexed citations

14.

Rajamanickam, Shivakumar, Jin‐hong Park, Santosh Timilsina, et al.. (2018). Abstract P6-06-04: Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach. Cancer Research. 78(4_Supplement). P6–6. 1 indexed citations

15.

Ling, Ling, Chase M. Carver, Santosh Timilsina, et al.. (2017). Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity. PLoS ONE. 12(11). e0188064–e0188064. 19 indexed citations

16.

Subbarayalu, Panneerdoss, Suryavathi Viswanadhapalli, Nourhan Abdelfattah, et al.. (2017). Cross-talk between miR-471-5p and autophagy component proteins regulates LC3-associated phagocytosis (LAP) of apoptotic germ cells. Nature Communications. 8(1). 598–598. 45 indexed citations

17.

Onyeagucha, Benjamin, Panneerdoss Subbarayalu, Subapriya Rajamanickam, et al.. (2017). Abstract 2336: Novel regulatory mechanisms for Bcl2-related Ovarian Killer (BOK) expression in breast cancer. Cancer Research. 77(13_Supplement). 2336–2336.

18.

Onyeagucha, Benjamin, Panneerdoss Subbarayalu, Nourhan Abdelfattah, et al.. (2017). Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die. Oncotarget. 8(49). 85984–85996. 19 indexed citations

19.

Rajamanickam, Subapriya, Panneerdoss Subbarayalu, Aparna Gorthi, et al.. (2016). Inhibition of FoxM1 -Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis. Clinical Cancer Research. 22(14). 3524–3536. 49 indexed citations

20.

Rajamanickam, Shivakumar, et al.. (2016). Abstract P2-03-04: Down-regulation of Bcl2-related ovarian killer (BOK) by miR-296-5p protects breast cancer cells from paclitaxel-induced apoptosis. Cancer Research. 76(4_Supplement). P2–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact